KBC Founded 1935
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 18
Average round size
info
The average size of a deal this fund participated in
$18M
Portfolio companies 13
Rounds per year 0.15
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.28
Exits 3
Stages of investment
Early Stage Venture
Late Stage Venture
Areas of investment
Biotechnology
Education
Energy
Health Care
Software
Summary

KBC appeared to be the Corporate Investor, which was created in 1935. The main department of described Corporate Investor is located in the Brussels. The fund was located in Europe if to be more exact in Belgium.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the KBC, startups are often financed by Gimv, Life Sciences Partners, Johnson & Johnson Development Corporation. The meaningful sponsors for the fund in investment in the same round are Gimv, Life Sciences Partners, Johnson & Johnson Development Corporation. In the next rounds fund is usually obtained by Johnson & Johnson Development Corporation, Life Sciences Partners, Gimv.

The top activity for fund was in 2009. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2014. The real fund results show that this Corporate Investor is 8 percentage points less often commits exit comparing to other companies. Opposing the other organizations, this KBC works on 12 percentage points more the average amount of lead investments. The fund is generally included in less than 2 deals every year.

Among the most successful fund investment fields, there are Clinical Trials, Pharmaceutical. Among the various public portfolio startups of the fund, we may underline Fnality International, CitizenLab, Aristo Music Technology For fund there is a match between the location of its establishment and the land of its numerous investments - Belgium. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.

Read more
Notable deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Stellar Labs
Corporate Training
E-Learning
EdTech
Education
Seed
2M22 Dec 2020 Belgium, Antwerpen
Wizata
Health Care
Manufacturing
Early Stage Venture
3M02 Jun 2020 Luxembourg, Luxembourg
ArtiQ
Artificial Intelligence
Health Care
Information Technology
Software
Seed
1M15 Jul 2019 Belgium, Leuven
Seed
2M11 Aug 2017
CitizenLab
Crowdsourcing
Government
Software
Seed
589K18 Nov 2016 Belgium, Brussels
Pronota
Biotechnology
Health Care
Health Diagnostics
Late Stage Venture
4M20 Jan 2012 Belgium, Ghent
arGEN-X
Biotechnology
Clinical Trials
Therapeutics
Early Stage Venture
4M11 Feb 2010 Netherlands, Rotterdam
Late Stage Venture
8M05 Nov 2009
arGEN-X
Biotechnology
Clinical Trials
Therapeutics
Early Stage Venture
13M10 Sep 2009 Netherlands, Rotterdam
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent KBC?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: